The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Regulation of hypoxia-inducible factor 1α is mediated by an O 2 -dependent degradation domain via the ubiquitin-proteasome pathway
Open accessAbstract
Hypoxia induces a group of physiologically important genes such as erythropoietin and vascular endothelial growth factor. These genes are transcriptionally up-regulated by hypoxia-inducible factor 1 (HIF-1), a global regulator that belongs to the basic helix-loop-helix PAS family. Although HIF-1 is a heterodimer composed of α and β subunits, its activity is primarily determined by hypoxia-induced stabilization of HIF-1α, which is otherwise rapidly degraded in oxygenated cells. We report the identification of an oxygen-dependent degradation (ODD) domain within HIF-1α that controls its degradation by the ubiquitin-proteasome pathway. The ODD domain consists of ≈200 amino acid residues, located in the central region of HIF-1α. Because portions of the domain independently confer degradation of HIF-1α, deletion of this entire region is required to give rise to a stable HIF-1α, capable of heterodimerization, DNA-binding, and transactivation in the absence of hypoxic signaling. Conversely, the ODD domain alone confers oxygen-dependent instability when fused to a stable protein, Gal4. Hence, the ODD domain plays a pivotal role for regulating HIF-1 activity and thereby may provide a means of controlling gene expression by changes in oxygen tension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“at moderate levels, ROS induce transcription of HIF1α, the founding member of the family of hypoxia-induced factors, and stabilize the encoded protein, which is normally hydroxylated within less than 5 min, by inhibiting the activity of the iron-dependent prolyl 4-hydroxylase (PHD) involved in its degradation29.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [29]
Experimental — accuracy not yet measuredIn the citing paper
“One or more of the Fe-S centers is a likely source (135, 160, 251), although the ubisemiquinone (QH•) binding site (143, 160, 200), or the flavin complex (216), per se, could also be sources”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S. W., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,541
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,438
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,707
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1128/mcb.12.12.5447-5454.1992 · DOI · Paper page
- 10.1128/mcb.14.9.6075-6086.1994 · DOI
Cited by
Sorted by citations
Items 201–300 of 1,002
Salghetti, S. E., Muratani, M., Wijnen, H., Futcher, B., & Tansey, W. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3118 · Cited by 265
Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy
Pringle, K. G., Kind, K. L., Sferruzzi-Perri, A. N., Thompson, J. G., & Roberts, C. T. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp046 · Cited by 259
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis.
Kimura, H., & Esumi, H. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3713 · Cited by 257
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 264
Kong, X., Lin, Z., Liang, D., Fath, D., Sang, N., & Caro, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2019-2028.2006 · Cited by 258
Expression of hypoxia-inducible factor-1α in the brain of rats during chronic hypoxia
Chavez, J. C., Agani, F. H., Pichiule, P., & LaManna, J. C. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.5.1937 · Cited by 257
Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario, A., von Tiehl, K., Rucker, N., Schwarz, M. A., Gill, P. S., & Gomer, C. J. (2000) · PubMed · Cited by 253
Review: Hypoxia-Inducible Factor-1 (HIF-1): A Novel Transcription Factor in Immune Reactions
Hellwig‐Bürgel, T., Stiehl, D. P., Wagner, A. E., Metzen, E., & JELKMANN, W. E. B. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.297 · Cited by 264
Pollenz, R. S. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00065-0 · Cited by 256
The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses
Bracken, C. P., Whitelaw, M. L., & Peet, D. J. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2370-y · Cited by 259
Mimura, I., Nangaku, M., Kanki, Y., Tsutsumi, S., Inoue, T., Kohro, T., Yamamoto, S., Fujita, T., Shimamura, T., Suehiro, J.-I., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06643-11 · Cited by 251
(2003) · PubMed · Cited by 250
HIF-1: Using Two Hands to Flip the Angiogenic Switch
Semenza, G. L. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026544214667 · Cited by 251
Protein transduction domain delivery of therapeutic macromolecules
van den Berg, A., & Dowdy, S. F. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.03.008 · Cited by 246
Hypoxic preconditioning protects against ischemic brain injury
Sharp, F. R., Ran, R., Lu, A., Tang, Y., Strauss, K. I., Glass, T. F., Ardizzone, T. D., & Bernaudin, M. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.26 · Cited by 242
Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression
Fandrey, J. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00577.2003 · Cited by 243
Lavista-Llanos, S., Centanin, L., Irisarri, M., Russo, D. M., Gleadle, J., Bocca, S. N., Muzzopappa, M., Ratcliffe, P. J., & Wappner, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6842-6853.2002 · Cited by 243
Kong, T., Eltzschig, H. K., Karhausen, J., Colgan, S. P., & Shelley, C. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401339101 · Cited by 242
O'Rourke, J. F., Tian, Y.-M., Ratcliffe, P. J., & Pugh, C. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2060 · Cited by 242
Hypoxia, HIF-1, and the Pathophysiologi of Common Human Diseases
Semenza, G. L., Agani, F., Feldser, D., Lyer, N., Kotch, L., Laughner, E., & Yu, 1. (2006) · Advances in Experimental Medicine and Biology · doi:10.1007/0-306-46825-5_12 · Cited by 241
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Edmonston, D. L., & Wolf, M. S. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0189-5 · Cited by 247
Coordinate Regulation of the Oxygen-Dependent Degradation Domains of Hypoxia-Inducible Factor 1α
Chan, D. A., Sutphin, P. D., Yen, S., & Giaccia, A. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6415-6426.2005 · Cited by 248
Silencing of the Hypoxia-Inducible Cell Death Protein BNIP3 in Pancreatic Cancer
Okami, J., Simeone, D. M., & Logsdon, C. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0089 · Cited by 237
Takeda, K., Cowan, A., & Fong, G.-H. (2007) · Circulation · doi:10.1161/circulationaha.107.701516 · Cited by 236
Lee, M. Y., Hwang, J.-T., Lee, H., Jung, S., Kang, I., Chi, S.-G., Kim, S. S., & Ha, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306104200 · Cited by 234
RetractedHayashi, M., Sakata, M., Takeda, T., Yamamoto, T., Okamoto, Y., Sawada, K., Kimura, A., Minekawa, R., Tahara, M., Tasaka, K., et al. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05599 · Cited by 234
Regulating cellular oxygen sensing by hydroxylation
Fandrey, J., Gorr, T. A., & Gassmann, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.005 · Cited by 234
Sumoylation increases HIF-1α stability and its transcriptional activity
Bae, S.-H., Jeong, J.-W., Park, J. A., Kim, S.-H., Bae, M.-K., Choi, S.-J., & Kim, K.-W. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.068 · Cited by 232
Elson, D. A., Ryan, H. E., Snow, J. W., Johnson, R. S., & Arbeit, J. M. (2000) · PubMed · Cited by 232
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Talib, W. H., Alsayed, A. R., Barakat, M. M., Abu-Taha, M. I., & Mahmod, A. I. (2021) · Biomedicines · doi:10.3390/biomedicines9101353 · Cited by 272
Chavez, J. C., & LaManna, J. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08922.2002 · Cited by 229
Hypoxia-Inducible Factor as an Angiogenic Master Switch
Hashimoto, T., & Shibasaki, F. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00033 · Cited by 242
Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases
Hirota, K., & Semenza, G. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.193 · Cited by 233
Hypoxia-inducible factor-1α regulates β cell function in mouse and human islets
Cheng, K., Ho, K., Stokes, R., Scott, C., Lau, S. M., Hawthorne, W. J., O’Connell, P. J., Loudovaris, T., Kay, T. W., Kulkarni, R. N., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci35846 · Cited by 230
Early Expression of Myocardial HIF-1α in Response to Mechanical Stresses
Kim, C., Cho, Y., Chun, Y., Park, J., & Kim, M.-S. (2002) · Circulation Research · doi:10.1161/hh0202.104923 · Cited by 228
Vleugel, M. M., Greijer, A. E., Shvarts, A., van der Groep, P., van Berkel, M., Aarbodem, Y., van Tinteren, H., Harris, A. L., van Diest, P. J., & van der Wall, E. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.019885 · Cited by 227
Miyazaki, K., Kawamoto, T., Tanimoto, K., Nishiyama, M., Honda, H., & Kato, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204938200 · Cited by 227
Hypoxia‐inducible factor‐1α contributes to hypoxia‐induced chemoresistance in gastric cancer
Liu, L., Ning, X., Sun, L. J., Zhang, H., Shi, Y., Guo, C., Han, S., Liu, J., Sun, S., Han, Z., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00643.x · Cited by 230
HIF‐1α and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome
Trastour, C., Benizri, E. I., Ettore, F., Ramaioli, A., Chamorey, E., Pouysségur, J., & Berra, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22436 · Cited by 233
Physiological role of reactive oxygen species as promoters of natural defenses
Roy, J., Galano, J., Durand, T., Guennec, J. L., & Lee, J. C. (2017) · The FASEB Journal · doi:10.1096/fj.201700170r · Cited by 234
Targeted protein degradation for cancer therapy
Hinterndorfer, M., Spiteri, V. A., Ciulli, A., & Winter, G. E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00817-8 · Cited by 263
MAP Kinases and Hypoxia in the Control of VEGF Expression
Berra, E., Pagès, G., & Pouysségur, J. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026506011458 · Cited by 222
Blancher, C., Moore, J. W., Talks, K., Houlbrook, S., & Harris, A. L. (2000) · PubMed · Cited by 220
Theodoropoulos, V. (2004) · European Urology · doi:10.1016/j.eururo.2004.04.008 · Cited by 223
Bracken, C. P., Fedele, A. O., Linke, S., Balrak, W., Lisy, K., Whitelaw, M. L., & Peet, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600288200 · Cited by 222
Hypoxic Preconditioning Induces Changes in HIF-1 Target Genes in Neonatal Rat Brain
Jones, N. M., & Bergeron, M. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00008 · Cited by 222
Baek, J. H., Mahon, P. C., Oh, J. C., Kelly, B., Krishnamachary, B., Pearson, M., Chan, D. A., Giaccia, A. J., & Semenza, G. L. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.011 · Cited by 218
Choi, H., Chun, Y., Kim, S.-W., Kim, M.-S., & Park, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025817 · Cited by 219
Narravula, S., & Colgan, S. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7543 · Cited by 220
Sivridis, E., Giatromanolaki, A., Gatter, K. C., Harris, A. L., Koukourakis, M. I., & for the Tumor and Angiogenesis Research Group (2002) · Cancer · doi:10.1002/cncr.10774 · Cited by 218
Liu, X. H., Kirschenbaum, A. M., Lü, M., Yao, S., Dosoretz, A. M., Holland, J. F., & Levine, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201095200 · Cited by 217
Ockaili, R. A., Natarajan, R., Salloum, F. N., Fisher, B. J., Jones, D. G., Fowler, A. A., & Kukreja, R. C. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00089.2005 · Cited by 214
HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels
Masson, N., & Ratcliffe, P. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00655 · Cited by 221
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
Ozer, A., & Bruick, R. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio863 · Cited by 214
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 217
Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors
Aprelikova, O. N., Chandramouli, G. V. R., Wood, M. J. A., Vasselli, J. R., Riss, J., Maranchie, J. K., Linehan, W. M., & Barrett, J. C. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20067 · Cited by 216
Hypoxia-Inducible Factor 1 Mediates Upregulation of Telomerase (hTERT)
Nishi, H., Nakada, T., Kyo, S., Inoue, M., Shay, J. W., & Isaka, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6076-6083.2004 · Cited by 219
Targeting the hypoxia-inducible factor (HIF) pathway in cancer
Poon, E., Harris, A. L., & Ashcroft, M. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001173 · Cited by 215
Nonhematological Mechanisms of Improved Sea-Level Performance after Hypoxic Exposure
Gore, C. J., Clark, S. A., & Saunders, P. U. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3180de49d3 · Cited by 212
Shen, X., Wan, C., Ramaswamy, G., Mavalli, M. D., Wang, Y., Duvall, C. L., Deng, L. F., Guldberg, R. E., Eberhart, A., Clemens, T. L., et al. (2009) · Journal of Orthopaedic Research® · doi:10.1002/jor.20886 · Cited by 211
Caniggia, I., & Winter, J. L. (2002) · Placenta · doi:10.1053/plac.2002.0815 · Cited by 211
Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis
Kim, Y., Nam, H. J., Lee, J., Park, D. Y., Kim, C., Yu, Y. S., Kim, D., Park, S. W., Bhin, J., Hwang, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10347 · Cited by 218
Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation
Karlenius, T., & Tonissen, K. F. (2010) · Cancers · doi:10.3390/cancers2020209 · Cited by 215
The Role of Mitochondria in the Regulation of Hypoxia-inducible Factor 1 Expression during Hypoxia
Agani, F. H., Pichiule, P., Chavez, J. C., & LaManna, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005643200 · Cited by 208
Angiogenesis in Wounds Treated by Microdeformational Wound Therapy
Erba, P., Ogawa, R., Ackermann, M., Adini, A., Miele, L. F., Dastouri, P., Helm, D. L., Mentzer, S. J., D’Amato, R. J., Murphy, G. F., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31820563a8 · Cited by 213
Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease
Giatromanolaki, A. N., Sivridis, E., Maltezos, E., Papazoglou, D., Simopoulos, C., Gatter, K. C., Harris, A. L., & Koukourakis, M. I. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.3.209 · Cited by 209
Metzen, E., Stiehl, D. P., Doege, K., Marxsen, J. H., Hellwig‐Bürgel, T., & JELKMANN, W. E. B. (2005) · Biochemical Journal · doi:10.1042/bj20041736 · Cited by 212
Involvement of Hypoxia-Inducible Factor 1 in Human Cancer.
Semenza, G. L. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.79 · Cited by 211
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Zhao, Y., Xing, C., Deng, Y., Ye, C., & Peng, H. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.039 · Cited by 231
Carcinogenic effect of nickel compounds
Lu, H., Shi, X., Costa, M., & Huang, C. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-8215-2 · Cited by 210
Hypoxia‐inducible factor‐1 and oncogenic signalling
Bárdos, J. I., & Ashcroft, M. A. (2004) · BioEssays · doi:10.1002/bies.20002 · Cited by 208
Holden, V. I., Breen, P., Houle, S., Dozois, C. M., & Bachman, M. A. (2016) · mBio · doi:10.1128/mbio.01397-16 · Cited by 218
Zhang, Q., Tang, X., Lu, Q., Zhang, Z., Brown, J. J., & Le, A. D. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0198 · Cited by 204
Pugh, C. W., & Ratcliffe, P. J. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00103-7 · Cited by 205
Chong, Z. Z., Kang, J., & Maiese, K. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200205000-00001 · Cited by 197
Regulation of gene expression by oxygen: NF-κB and HIF-1, two extremes
Michiels, C., Minet, E., Mottet, D., & Raes, M. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01045-6 · Cited by 202
Mechanisms of adaptive angiogenesis to tissue hypoxia
Fong, G. (2008) · Angiogenesis · doi:10.1007/s10456-008-9107-3 · Cited by 212
Vaux, E. C., Metzen, E., Yeates, K. M., & Ratcliffe, P. J. (2001) · Blood · doi:10.1182/blood.v98.2.296 · Cited by 200
Kevin, L. G., Novalija, E., & Stowe, D. F. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000180999.81013.d0 · Cited by 197
Jung, Y., Isaacs, J. S., Lee, S., Trepel, J. B., Liu, Z.-G., & Neckers, L. (2003) · Biochemical Journal · doi:10.1042/bj20021279 · Cited by 193
Heme-based sensors in biological systems
Rodgers, K. R. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80028-3 · Cited by 197
Jab1 interacts directly with HIF-1α and regulates its stability
Bae, M.-K., Ahn, M.-Y., Jeong, J.-W., Bae, M.-H., Lee, Y. M., Bae, S.-K., Park, J.-W., Kim, K.-R., & Kim, K.-W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100442200 · Cited by 196
Mojsilovic‐Petrovic, J., Callaghan, D., Cui, H., Dean, C., Stanimirovic, D. B., & Zhang, W. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-12 · Cited by 196
Ai, Z., Lü, Y., Qiu, S., & Fan, Z. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.009 · Cited by 196
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
Berra, E., Milanini, J., Richard, D. E., Gall, M. L., Viñals, F., Gothié, E., Roux, D., Pagès, G., & Pouysségur, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00423-8 · Cited by 195
Cancer Drug Discovery and Development
Humphrey, J. S., Price, K., Gupta, E., Baxter, A. R. W., Bird, J., Sonnichsen, D. S., & Naglich, J. G. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-325-5_21 · Cited by 195
Palmer, L. A., Gaston, B. M., & Johns, R. A. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1197 · Cited by 191
HIF-1: the knowns and unknowns of hypoxia sensing.
Zagórska, A., & Dulak, J. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3545 · Cited by 194
Semenza, G. L. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033498 · Cited by 192
O 2 sensing, mitochondria and ROS signaling: The fog is lifting
Waypa, G. B., Smith, K. A., & Schumacker, P. T. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.01.002 · Cited by 190
Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis
Giatromanolaki, A. N., Sivridis, E., Maltezos, E. S., Athanassou, N., Papazoglou, D., Gatter, K. C., Harris, A. L., & Koukourakis, M. I. (2003) · Arthritis Research & Therapy · doi:10.1186/ar756 · Cited by 190
Gao, N., Ding, M., Zheng, J. Z., Zhang, Z., Leonard, S. S., Liu, K. J., Shi, X., & Jiang, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200082200 · Cited by 191
Chilov, D., Camenisch, G., Kvietikova, I., Ziegler, U., Gassmann, M., & Wenger, R. H. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.8.1203 · Cited by 194
Storci, G., Sansone, P., Mari, S., D’Uva, G., Tavolari, S., Guarnieri, T., Taffurelli, M., Ceccarelli, C., Santini, D., Chieco, P., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22264 · Cited by 188
Reactive oxygen species and cellular oxygen sensing
Cash, T. P., Pan, Y., & Simon, M. C. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.07.001 · Cited by 195
Pore, N., Jiang, Z., Shu, H. G., Bernhard, E. J., Kao, G. D., & Maity, A. M. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0234 · Cited by 190
Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia‐inducible factor‐1α
Moon, E., Jeong, C., Jeong, J., Kim, K. R., Yu, D., Murakami, S., Kim, C. W., & Kim, K. (2003) · The FASEB Journal · doi:10.1096/fj.03-0153fje · Cited by 186
Ultrasensitive response motifs: basic amplifiers in molecular signalling networks
Zhang, Q., Bhattacharya, S., & Andersen, M. E. (2013) · Open Biology · doi:10.1098/rsob.130031 · Cited by 186
Mitochondrial Function in Sepsis
Arulkumaran, N., Deutschman, C. S., Pinsky, M. R., Zuckerbraun, B. S., Schumacker, P. T., Gómez, H., Gómez, A., Murray, P. T., & Kellum, J. A. (2016) · Shock · doi:10.1097/shk.0000000000000463 · Cited by 199
Groulx, I., & Lee, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5319-5336.2002 · Cited by 188
Metadata
- Authors
- Huang, L. E., Gu, J., Schau, M., & Bunn, H. F.
- Affiliations
- Division of Hematology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115
- Brigham and Women's Hospital (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-07-07
- Volume
- 95
- Issue
- 14
- Pages
- 7987-7992
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC20916
- OpenAlex
- W2075054245
- Cited by
- 2,113
- References
- 40
- Citations by year
- 2026: 36 · 2025: 36 · 2024: 39 · 2023: 43 · 2022: 49 · 2021: 56 · 2020: 49 · 2019: 60 · 2018: 59 · 2017: 56 · 2016: 70 · 2015: 65 · 2014: 78 · 2013: 92 · 2012: 74
- FWCI
- 28.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK041234, R0-DK41234, F32-DK09365, F32DK009365)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- hypoxia-inducible factor-1α, oxygen-dependent degradation domain, ubiquitin-proteasome system, protein degradation, hypoxia, oxygen sensing, transcriptional regulation, erythropoietin, vascular endothelial growth factor
- MeSH terms
- Animals, Cell Line, Cysteine Endopeptidases, DNA, DNA-Binding Proteins, Multienzyme Complexes, Nuclear Proteins, Oxygen, Protein Binding, Transcription Factors, Ubiquitins, Signal Transduction, Cell Hypoxia, Dimerization, Proteasome Endopeptidase Complex, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review